ACADIA Pharmaceuticals
ACAD
#4034
Rank
HK$23.18 B
Marketcap
HK$134.12
Share price
-2.73%
Change (1 day)
-26.85%
Change (1 year)

EPS for ACADIA Pharmaceuticals (ACAD)

EPS in 2026 (TTM): HK$16.61

According to ACADIA Pharmaceuticals's latest financial reports the company's current EPS (TTM) is HK$16.70. In 2025 the company made an earnings per share (EPS) of HK$18.19 an increase over its 2024 EPS that were of HK$10.66.

EPS history for ACADIA Pharmaceuticals from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)HK$16.61-8.69%
2025HK$18.1970.59%
2024HK$10.66-457.89%
2023-HK$2.98-71.64%
2022-HK$10.5027.62%
2021-HK$8.23-41.67%
2020-HK$14.1112.5%
2019-HK$12.54-17.95%
2018-HK$15.29-17.02%
2017-HK$18.420.43%
2016-HK$18.3443.56%
2015-HK$12.7873.4%
2014-HK$7.37
2012-HK$2.90

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$52.36 213.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$5.57-66.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$242.15 1,350.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$35.43 112.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Vanda Pharmaceuticals
VNDA
-HK$36.22-316.90%๐Ÿ‡บ๐Ÿ‡ธ USA